Back to Search
AMUDHA PALANI, MD
MD
Family Medicine Physician
NPI: 1952428682IndividualAccepts Medicare
Specialties, Licenses & Credentials
Specialist
Specialist
Code: 174400000X
0101240408(VA)
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
0101240408(VA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 1998
Research & Publications (20)
The discovery of potent antitumor agent C11-deoxypsymberin/irciniastatin A: total synthesis and biology of advanced psymberin analogs.
PMID 19199777·Org Lett·2009
8-other
Spiro-piperidine azetidinones as potent TRPV1 antagonists.
PMID 19114307·Bioorg Med Chem Lett·2009
7-preclinical
Selective enrichment of cysteine-containing peptides using SPDP-functionalized superparamagnetic Fe(3)O(4)@SiO(2) nanoparticles: application to comprehensive proteomic profiling.
PMID 18563925·J Proteome Res·2008
8-other
13C CPMAS NMR spectroscopy as a versatile and quantitative tool for determination of mercury adsorption capacity in thiol-functionalized mesoporous silica SBA-1.
PMID 18338904·Anal Chem·2008
8-other
Discovery and development of small-molecule chemokine coreceptor CCR5 antagonists.
PMID 16686527·J Med Chem·2006
6-review
Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas.
PMID 16570926·J Med Chem·2006
7-preclinical
Interaction of small molecule inhibitors of HIV-1 entry with CCR5.
PMID 16494916·Virology·2006
8-other
Bicyclic[4.1.0]heptanes as phenyl replacements for melanin concentrating hormone receptor antagonists.
PMID 16442800·Bioorg Med Chem·2006
7-preclinical
Biaryl diamides as potent melanin concentrating hormone receptor 1 antagonists.
PMID 16202583·Bioorg Med Chem Lett·2005
8-other
Biaryl ureas as potent and orally efficacious melanin concentrating hormone receptor 1 antagonists for the treatment of obesity.
PMID 16033253·J Med Chem·2005
7-preclinical
Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics.
PMID 15801820·J Med Chem·2005
7-preclinical
Manipulation of N,O-nucleophilicity: efficient formation of 4-N-substituted 2,4-dihydro-3H-1,2,4-triazolin-3-ones.
PMID 15575688·Org Lett·2004
8-other
Isopropyl amide derivatives of potent and selective muscarinic M2 receptor antagonists.
PMID 15026073·Bioorg Med Chem Lett·2004
8-other
Structure-activity relationship studies: M2 and CCR5 receptor antagonists.
PMID 12769714·Curr Top Med Chem·2003
6-review
Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry.
PMID 12692222·J Virol·2003
8-other
Oximino-piperidino-piperidine-based CCR5 antagonists. Part 2: synthesis, SAR and biological evaluation of symmetrical heteroaryl carboxamides.
PMID 12639564·Bioorg Med Chem Lett·2003
7-preclinical
Biological evaluation and interconversion studies of rotamers of SCH 351125, an orally bioavailable CCR5 antagonist.
PMID 12639563·Bioorg Med Chem Lett·2003
8-other
Piperazine-based CCR5 antagonists as HIV-1 inhibitors. III: synthesis, antiviral and pharmacokinetic profiles of symmetrical heteroaryl carboxamides.
PMID 12565973·Bioorg Med Chem Lett·2003
7-preclinical
Synthesis, SAR, and biological evaluation of oximino-piperidino-piperidine amides. 1. Orally bioavailable CCR5 receptor antagonists with potent anti-HIV activity.
PMID 12086500·J Med Chem·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12655 WARWICK BLVD, SUITE A
NEWPORT NEWS, VA 23606 - Phone
- (757) 595-9880
Quick Facts
- NPI
- 1952428682
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile